✦ LIBER ✦

Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer

✍ Scribed by Phillip L Ross; Iona Cheng; Xin Liu; Mine S Cicek; Peter R Carroll; Graham Casey; John S Witte

Book ID: 115011808
Publisher: BioMed Central
Year: 2009
Tongue: English
Weight: 238 KB
Volume: 9
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-9-69

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2286 FREQUENCIES OF PROSTATE CANCER RISK

2286 FREQUENCIES OF PROSTATE CANCER RISK VARIANTS IN EARLY ONSET AND FAMILIAL PROSTATE CANCER

✍ Helfand, Brian T.; McGuire, Barry B.; Delli-Zotti, Kimberly A.; Catalona, Willia 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 239 KB

Comparison of High-Dose IMRT (86.4 Gy) t

Comparison of High-Dose IMRT (86.4 Gy) to Combined Brachytherapy Plus IMRT for Intermediate-Risk Prostate Cancer

✍ Spratt, D.E.; Kollmeier, M.; Zumsteg, Z.; Pirus, G.; Yamada, Y.; Cohen, G.; Polk 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Identifying the early-onset cases of bre

Identifying the early-onset cases of breast and colorectal cancers most likely to carry a germline mutation in a ‘high-risk’ cancer predisposition gene

✍ M. Southey; M. Jenkins; S. Ramus; J. Dowty; G. Dite; G. Byrnes; G. Giles; M. McC 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 85 KB

389 Three-year prostate cancer screening

389 Three-year prostate cancer screening program in high risk families: High detection associated with the number of affected relatives and early onset

✍ A. Valeri; V. Joulin; M.P. Moineau; R. Azzouzi; L. Cormier; L. Doucet; P. Mangin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 207 KB

Toxicity and early treatment outcomes in

Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy

✍ Pirus Ghadjar; Tamara Keller; Cyrill A. Rentsch; Bernhard Isaak; Frank Behrensme 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Toxicity Assessment of Pelvic Intensity-

Toxicity Assessment of Pelvic Intensity-Modulated Radiotherapy With Hypofractionated Simultaneous Integrated Boost to Prostate for Intermediate- and High-Risk Prostate Cancer

✍ Robert McCammon; Kyle E. Rusthoven; Brian Kavanagh; Sherri Newell; Francis Newma 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 282 KB